Administrative Core
Administrative Core
批准号:
7882871
负责人:
SAID M SEBTI
金额:
$4.98万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2010-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goal of the Administration Core for the NCDDG is to provide oversight and coordination for the scientific, administrative, fiscal and regulatory aspects of the NCDDG. Specific functions of the core include:
(1) Scientific integration of the programs, review of quarterly progress reports of each program, refining goals, prioritizing and realigning resources to assure the most efficient way of advancing the best lead.
This will be accomplished by the guidance of the steering committee under the leadership of the NCDDG Principal Investigator in consultation with the External Advisory Board {EAB) and the NCI staff assigned to this NCDDG.
(2) Scientific planning and coordination including organizing regular meetings with program and core leaders as well as visits by members of the EAB.
(3) Fiscal planning and accountability including communication with the NCI staff about fiscal and
administrative matters, and the proper day-to-day expenditures within each program and core;
(4) Preparation of non-competing continuation progress reports and documentation of all activities related to the NCDDG, including documenting usage of all cores and productivity measures such as joint publications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting Mutant KRAS for Cancer Therapy
-
批准号:9437725
-
项目类别:
-
资助金额:$92.46万
-
财政年份:2016
-
负责人:SAID M SEBTI
-
依托单位:
Targeting Mutant KRAS for Cancer Therapy
-
批准号:10004247
-
项目类别:
-
资助金额:$41.52万
-
财政年份:2016
-
负责人:SAID M SEBTI
-
依托单位:
Targeting Mutant KRAS for Cancer Therapy
-
批准号:9233953
-
项目类别:
-
资助金额:$92.46万
-
财政年份:2016
-
负责人:SAID M SEBTI
-
依托单位:
Targeting Mutant KRAS for Cancer Therapy
-
批准号:10204898
-
项目类别:
-
资助金额:$83.93万
-
财政年份:2016
-
负责人:SAID M SEBTI
-
依托单位:
Targeting Mutant KRAS for Cancer Therapy
-
批准号:10413104
-
项目类别:
-
资助金额:$77.12万
-
财政年份:2016
-
负责人:SAID M SEBTI
-
依托单位:
Biological and Pharmacological Evaluations of RhoGEF, GGTase I and Rho kinase inh
-
批准号:7882868
-
项目类别:
-
资助金额:$19.8万
-
财政年份:2009
-
负责人:SAID M SEBTI
-
依托单位:
Targeting Signal Transduction Pathways for Cancer Drug Discovery
-
批准号:8034268
-
项目类别:
-
资助金额:$193.07万
-
财政年份:2007
-
负责人:SAID M SEBTI
-
依托单位:
Targeting Signal Transduction Pathways for Cancer Drug Discovery
-
批准号:7767743
-
项目类别:
-
资助金额:$199.24万
-
财政年份:2007
-
负责人:SAID M SEBTI
-
依托单位:
Targeting Signal Transduction Pathways for Cancer Drug Discovery
-
批准号:7759306
-
项目类别:
-
资助金额:$8.62万
-
财政年份:2007
-
负责人:SAID M SEBTI
-
依托单位:
Targeting Signal Transduction Pathways for Cancer Drug Discovery
-
批准号:7581046
-
项目类别:
-
资助金额:$195.04万
-
财政年份:2007
-
负责人:SAID M SEBTI
-
依托单位:
Targeting Signal Transduction Pathways for Cancer Drug Discovery
-
批准号:7186767
-
项目类别:
-
资助金额:$183.59万
-
财政年份:2007
-
负责人:SAID M SEBTI
-
依托单位:
Targeting Signal Transduction Pathways for Cancer Drug Discovery
-
批准号:8016168
-
项目类别:
-
资助金额:$8.87万
-
财政年份:2007
-
负责人:SAID M SEBTI
-
依托单位:
Development of Proteasome Selective Inhibitors for Cancer Therapy
-
批准号:7214567
-
项目类别:
-
资助金额:$28.14万
-
财政年份:2006
-
负责人:SAID M SEBTI
-
依托单位:
ADMINISTRATION
-
批准号:6924402
-
项目类别:
-
资助金额:$3.77万
-
财政年份:2005
-
负责人:SAID M SEBTI
-
依托单位:
HIGH THROUGHPUT SCREENING AND MOLECULAR MODELING
-
批准号:6924405
-
项目类别:
-
资助金额:$18.84万
-
财政年份:2005
-
负责人:SAID M SEBTI
-
依托单位:
BIOLOGICAL AND PHARMACOLOGICAL EVALUATIONS OF RHOGEF, GGTASE I AND RHO KINASE INH
-
批准号:6924399
-
项目类别:
-
资助金额:$16.46万
-
财政年份:2005
-
负责人:SAID M SEBTI
-
依托单位:
Growth Factor as Anti-angiogenesis Agents
-
批准号:6954662
-
项目类别:
-
资助金额:$32.49万
-
财政年份:2004
-
负责人:SAID M SEBTI
-
依托单位:
Growth Factor as Anti-angiogenesis Agents
-
批准号:7247936
-
项目类别:
-
资助金额:$32.19万
-
财政年份:2004
-
负责人:SAID M SEBTI
-
依托单位:
Growth Factor as Anti-angiogenesis Agents
-
批准号:6875930
-
项目类别:
-
资助金额:$33.98万
-
财政年份:2004
-
负责人:SAID M SEBTI
-
依托单位:
Growth Factor as Anti-angiogenesis Agents
-
批准号:7107134
-
项目类别:
-
资助金额:$32.42万
-
财政年份:2004
-
负责人:SAID M SEBTI
-
依托单位:
海外基金